DYN FY 2023 Earnings — Dyne Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DYNDyne Therapeutics, Inc.

$3B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$2M

Operating Income

-$242M

Net Income

-$236M

EPS (Diluted)

$-3.95

Cash Flow

Operating Cash Flow

-$188M

Free Cash Flow

-$189M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$165M

Total Liabilities

$74M

Stockholders' Equity

$91M

Cash & Equivalents

$122M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$2M	$0	—
Operating Income	-$242M	-$171M	-41.6%
Net Income	-$236M	-$168M	-40.4%